In BC, the oncogenic TFs have been mainly divided into three groups: steroid receptors, such as estrogen receptors (ERs), resident nuclear transcription factors that are activated through serine kinases, and latent cytoplasmic factors which are activated by serine or tyrosine kinases from the cell membrane or cytoplasm [48]. This evidence concerns the gene ESR1 and breast cancer.